الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 89 |  |  |
| | | from | 89 | | |
Abstract
“Comparing efficacy of Topical anti glaucoma Medication in monitoring rise in IOP following Nd-YAG Capsulotomy.” an Open-label, Randomized hospital based study conducted in the Ophthalmology Department of police Hospital . from February 2020-August –2020
40 Patients in the age group between 40 to 70 years having diminision of vision due to posterior capsular opacification visiting the Out Patient were selected .
-Study subjects who consent to be a part of the study were matched in terms of age and sex
-In the study 25 were males and remaining 15 were females.
- In the study the majority of the patients were in the age group of 56- 65 years
i.e. 43 patients.
-The minimum age of the patient selected for the study was 40 years and maximum age was 83 years the mean for the 40 patients was calculated as 63.19.
-20 patients received 1 DROP of brimondine eye drops 1 hour before and 1 hour after the procedure and for 7 days after the procedure.
Most of the patients i.e. 60 in our study had a 2 line improvement in the snellen’s chart.
-The Complications seen after ND YAG laser Capsulotomy 40 patients did not have any complications after the procedure , 4 patients had IOL pitting and 1 patient had Cystoid Macular Edema.
The patients undergoing ND YAG laser capsulotomy for Posterior Capsular Opacification require a close monitoring in IOP as the rise in transient. Simple premedication with topical Brimonidine 1 hour prior and 1 hour after the procedure is an easy and effective way in managing this complication.
The rise in IOP 1 hour after the procedure was significant in bothself controll and Brimonidine group . The rise in IOP was transient and continued to be high 4 hours after the procedure. The IOP normalised on the 3rd and 7th day of treatment . It was found out that the patients treated in the self control group had a mean rise in IOP of 4.18 mm Hg 1 hour after the procedure while the patients in th Brimonidine group had a mean rise of 3.32mm Hg 1 hour after the procedure. The chi- square test comparing rise in IOP in self control and Brimonidine group showed the p= 0.016 which was statistically very significant . Hence our study concludes that Topical Brimonidine eye drops controls the transient rise in IOP better than self control l following ND YAG Capsulotomy.